Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future trends in weight management.

C D Still1

  • 1High Risk Obesity Clinic, Pennsylvania State Geisinger Health System, Danville 17822-2111, USA. cstill@psghs.edu

The Journal of the American Osteopathic Association
|January 7, 2000
PubMed
Summary

While no single obesity treatment exists, future pharmacotherapy targets include leptin and gastrointestinal hormones for appetite suppression. Lifestyle changes remain crucial alongside any new drug development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of multi-frequency bioelectrical impedance analysis for the assessment of body composition in individuals with obesity.

Obesity science & practice·2019
Same author

Response to 'Regression to the mean, apparent data errors, and biologically extraordinary results'.

International journal of obesity (2005)·2017
Same author

Changes in telomere length 3-5 years after gastric bypass surgery.

International journal of obesity (2005)·2017
Same author

Electronically captured, patient-reported physical function: an important vital sign in obesity medicine.

Obesity science & practice·2017
Same author

Gene expression profiling in subcutaneous, visceral and epigastric adipose tissues of patients with extreme obesity.

International journal of obesity (2005)·2013
Same author

The effect of weight loss surgery on the severity of psoriasis.

The British journal of dermatology·2012

Area of Science:

  • Pharmacology
  • Metabolic Research
  • Obesity Treatment

Background:

  • Obesity is a complex condition with ongoing challenges in effective treatment.
  • Current therapeutic strategies require further advancement for optimal patient outcomes.

Purpose of the Study:

  • To review potential future pharmacotherapy targets for obesity treatment.
  • To discuss emerging drug candidates and their mechanisms of action.
  • To emphasize the continued importance of lifestyle interventions.

Main Methods:

  • Literature review of current and emerging obesity pharmacotherapy research.
  • Discussion of molecular targets including OB protein (leptin), neuropeptides, and gastrointestinal hormone receptors.
  • Analysis of receptor agonists for appetite suppression and energy expenditure enhancement.

Main Results:

  • Identified several promising molecular targets for anti-obesity drug development, such as leptin, beta 3-adrenergic receptors, and gastrointestinal hormones (cholecystokinin, bombesin, glucagon-like peptide-1).
  • Receptor agonists for these targets show potential in reducing appetite and meal size.
  • Research modalities for these targets are under active investigation.

Conclusions:

  • No single "magic bullet" exists for obesity treatment; a multifaceted approach is necessary.
  • Future pharmacotherapy holds promise, targeting specific molecular pathways.
  • Diet, exercise, and behavior modification are fundamental components of any obesity management plan.

Related Experiment Videos